Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03920358 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study

Study acronym: FRITS
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Dec 30, 2023 to Jun 9, 2023v4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 156
    • Site details revised
    v3
  3. Primary completion date: Apr 30, 2021 to Dec 30, 2023v2 Show 5 more changesShow less
    • Study completion date: Sep 30, 2024 to Dec 30, 2027
    • Interventions: FRED and FRED Jr (Device) to FRED, FRED Jr and FRED X (Device)
    • Eligibility criteria expanded, about 8 words
    • Study description expanded, about 3 words
    • Study title expanded, about 3 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms
Trial Details
NCT Number NCT03920358
Lead Sponsor Microvention-Terumo, Inc.
Conditions
(from sponsor)		 Intracranial Aneurysm
Related terms Intracranial Aneurysm
Enrollment 156 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov